This inventor holds 1 USPTO granted patent. Top assignee: Changchun Institute of Biological Products, Ministry of Public Health. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Lingjiu Liu: Innovator in Hepatitis A Vaccine Development
Introduction
Lingjiu Liu is a prominent inventor based in Changchun, China. He has made significant contributions to the field of vaccine development, particularly in the area of hepatitis A. His innovative work has the potential to improve public health outcomes through enhanced vaccine stability and accessibility.
Latest Patents
Lingjiu Liu holds a patent for a freeze-dried hepatitis A attenuated live vaccine and its stabilizer. This invention relates to a lyophilized attenuated hepatitis A vaccine that can be stored at ambient temperature for extended periods. The patent also includes a method for producing this vaccine, as well as a stabilizer that improves the thermostability of the lyophilized live vaccine during processing and storage.
Career Highlights
Lingjiu Liu is affiliated with the Changchun Institute of Biological Products, which operates under the Ministry of Public Health. His work at this institute has been instrumental in advancing vaccine technology and ensuring the availability of effective vaccines for hepatitis A.
Collaborations
Lingjiu Liu has collaborated with notable colleagues, including Ben Liang and Wei Wang. These partnerships have contributed to the successful development and implementation of his innovative vaccine solutions.
Conclusion
Lingjiu Liu's contributions to vaccine development, particularly in the area of hepatitis A, highlight his role as a key innovator in public health. His patented work promises to enhance vaccine stability and accessibility, ultimately benefiting communities worldwide.